Comments
Loading...

KalVista Pharma

KALVNASDAQ
Logo brought to you by Benzinga Data
$11.18
0.494.58%
Last update: 12:16 PM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$32.00
Lowest Price Target1
$20.00
Consensus Price Target1
$26.00

KalVista Pharma (NASDAQ:KALV) Stock, Analyst Ratings, Price Targets, Forecasts

KalVista Pharmaceuticals Inc has a consensus price target of $26 based on the ratings of 5 analysts. The high is $32 issued by Needham on September 6, 2024. The low is $20 issued by HC Wainwright & Co. on September 6, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Needham, and HC Wainwright & Co. on September 6, 2024, September 6, 2024, and July 15, 2024, respectively. With an average price target of $24 between HC Wainwright & Co., Needham, and HC Wainwright & Co., there's an implied 114.67% upside for KalVista Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jun
0
0
0
0
Jul
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Needham
SVB Leerink
Stifel

1calculated from analyst ratings

Analyst Ratings for KalVista Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for KalVista Pharma (KALV) stock?

A

The latest price target for KalVista Pharma (NASDAQ:KALV) was reported by Cantor Fitzgerald on September 9, 2024. The analyst firm set a price target for $0.00 expecting KALV to fall to within 12 months (a possible -100.00% downside). 13 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for KalVista Pharma (KALV)?

A

The latest analyst rating for KalVista Pharma (NASDAQ:KALV) was provided by Cantor Fitzgerald, and KalVista Pharma reiterated their overweight rating.

Q

When was the last upgrade for KalVista Pharma (KALV)?

A

There is no last upgrade for KalVista Pharma

Q

When was the last downgrade for KalVista Pharma (KALV)?

A

There is no last downgrade for KalVista Pharma.

Q

When is the next analyst rating going to be posted or updated for KalVista Pharma (KALV)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of KalVista Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for KalVista Pharma was filed on September 9, 2024 so you should expect the next rating to be made available sometime around September 9, 2025.

Q

Is the Analyst Rating KalVista Pharma (KALV) correct?

A

While ratings are subjective and will change, the latest KalVista Pharma (KALV) rating was a reiterated with a price target of $0.00 to $0.00. The current price KalVista Pharma (KALV) is trading at is $11.18, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch